Suppan, Christoph
Funding for this research was provided by:
Medical University of Graz
Article History
Received: 15 February 2022
Accepted: 5 April 2022
First Online: 6 May 2022
Conflict of interest
: C. Suppan: Consulting or Advisory Role: Roche, Novartis, Pfizer, Lilly, AstraZeneca, Daiichi Sankyo; Speakers’ Bureau: Roche, Novartis, Pfizer, Lilly, Pierre Fabre; Travel, Accommodations, Expenses: Roche, Novartis, Pfizer, Astellas.